Vanguard Personalized Indexing Management, LLC Amicus Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 19,349 shares of FOLD stock, worth $174,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,349
Previous 10,057
92.39%
Holding current value
$174,334
Previous $107,000
70.09%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$264 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$256 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$220 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$218 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$209 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.53B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...